Logo image of ICHR

ICHOR HOLDINGS LTD (ICHR) Stock Fundamental Analysis

NASDAQ:ICHR - Nasdaq - KYG4740B1059 - Common Stock - Currency: USD

15.78  -0.53 (-3.25%)

After market: 15.78 0 (0%)

Fundamental Rating

4

ICHR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. The financial health of ICHR is average, but there are quite some concerns on its profitability. ICHR is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ICHR was profitable.
In the past year ICHR had a positive cash flow from operations.
In multiple years ICHR reported negative net income over the last 5 years.
Each year in the past 5 years ICHR had a positive operating cash flow.
ICHR Yearly Net Income VS EBIT VS OCF VS FCFICHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M 80M

1.2 Ratios

With a Return On Assets value of -1.63%, ICHR is not doing good in the industry: 61.82% of the companies in the same industry are doing better.
ICHR's Return On Equity of -2.34% is on the low side compared to the rest of the industry. ICHR is outperformed by 60.91% of its industry peers.
Industry RankSector Rank
ROA -1.63%
ROE -2.34%
ROIC N/A
ROA(3y)0.02%
ROA(5y)2.26%
ROE(3y)0.6%
ROE(5y)4.81%
ROIC(3y)N/A
ROIC(5y)N/A
ICHR Yearly ROA, ROE, ROICICHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

ICHR's Gross Margin of 12.20% is on the low side compared to the rest of the industry. ICHR is outperformed by 89.09% of its industry peers.
ICHR's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ICHR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 12.2%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.35%
GM growth 5Y-2.65%
ICHR Yearly Profit, Operating, Gross MarginsICHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

More info and screens

4

2. Health

2.1 Basic Checks

ICHR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ICHR has more shares outstanding
Compared to 5 years ago, ICHR has more shares outstanding
Compared to 1 year ago, ICHR has an improved debt to assets ratio.
ICHR Yearly Shares OutstandingICHR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ICHR Yearly Total Debt VS Total AssetsICHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 2.54 indicates that ICHR is not a great score, but indicates only limited risk for bankruptcy at the moment.
ICHR has a Altman-Z score of 2.54. This is comparable to the rest of the industry: ICHR outperforms 45.45% of its industry peers.
The Debt to FCF ratio of ICHR is 12.16, which is on the high side as it means it would take ICHR, 12.16 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 12.16, ICHR perfoms like the industry average, outperforming 47.27% of the companies in the same industry.
ICHR has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
ICHR has a Debt to Equity ratio (0.17) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 12.16
Altman-Z 2.54
ROIC/WACCN/A
WACC10.96%
ICHR Yearly LT Debt VS Equity VS FCFICHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 3.09 indicates that ICHR has no problem at all paying its short term obligations.
With a Current ratio value of 3.09, ICHR perfoms like the industry average, outperforming 50.91% of the companies in the same industry.
ICHR has a Quick Ratio of 1.32. This is a normal value and indicates that ICHR is financially healthy and should not expect problems in meeting its short term obligations.
ICHR's Quick ratio of 1.32 is on the low side compared to the rest of the industry. ICHR is outperformed by 79.09% of its industry peers.
Industry RankSector Rank
Current Ratio 3.09
Quick Ratio 1.32
ICHR Yearly Current Assets VS Current LiabilitesICHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 716.67% over the past year.
The earnings per share for ICHR have been decreasing by -33.82% on average. This is quite bad
ICHR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.41%.
ICHR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.46% yearly.
EPS 1Y (TTM)716.67%
EPS 3Y-63.79%
EPS 5Y-33.82%
EPS Q2Q%233.33%
Revenue 1Y (TTM)13.41%
Revenue growth 3Y-8.18%
Revenue growth 5Y6.46%
Sales Q2Q%21.39%

3.2 Future

Based on estimates for the next years, ICHR will show a very strong growth in Earnings Per Share. The EPS will grow by 86.61% on average per year.
The Revenue is expected to grow by 12.03% on average over the next years. This is quite good.
EPS Next Y388.41%
EPS Next 2Y206.76%
EPS Next 3Y123.87%
EPS Next 5Y86.61%
Revenue Next Year12.02%
Revenue Next 2Y9.31%
Revenue Next 3Y8.16%
Revenue Next 5Y12.03%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ICHR Yearly Revenue VS EstimatesICHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B
ICHR Yearly EPS VS EstimatesICHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 42.65, the valuation of ICHR can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of ICHR is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 26.25, ICHR is valued quite expensively.
A Price/Forward Earnings ratio of 10.48 indicates a reasonable valuation of ICHR.
90.00% of the companies in the same industry are more expensive than ICHR, based on the Price/Forward Earnings ratio.
ICHR's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.15.
Industry RankSector Rank
PE 42.65
Fwd PE 10.48
ICHR Price Earnings VS Forward Price EarningsICHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ICHR indicates a somewhat cheap valuation: ICHR is cheaper than 63.64% of the companies listed in the same industry.
ICHR's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 51.64
EV/EBITDA 21.24
ICHR Per share dataICHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ICHR's earnings are expected to grow with 123.87% in the coming years.
PEG (NY)0.11
PEG (5Y)N/A
EPS Next 2Y206.76%
EPS Next 3Y123.87%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ICHR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ICHOR HOLDINGS LTD

NASDAQ:ICHR (5/30/2025, 8:03:35 PM)

After market: 15.78 0 (0%)

15.78

-0.53 (-3.25%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)05-05 2025-05-05/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners95.77%
Inst Owner Change4.84%
Ins Owners1.54%
Ins Owner Change14.68%
Market Cap538.41M
Analysts80
Price Target33.83 (114.39%)
Short Float %3.12%
Short Ratio2.54
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-32.26%
Min EPS beat(2)-55.02%
Max EPS beat(2)-9.51%
EPS beat(4)2
Avg EPS beat(4)2.24%
Min EPS beat(4)-55.02%
Max EPS beat(4)63.4%
EPS beat(8)3
Avg EPS beat(8)-551.18%
EPS beat(12)6
Avg EPS beat(12)-361.29%
EPS beat(16)7
Avg EPS beat(16)-272.8%
Revenue beat(2)0
Avg Revenue beat(2)-1.95%
Min Revenue beat(2)-2.16%
Max Revenue beat(2)-1.73%
Revenue beat(4)2
Avg Revenue beat(4)-0.3%
Min Revenue beat(4)-2.16%
Max Revenue beat(4)1.83%
Revenue beat(8)5
Avg Revenue beat(8)-0.07%
Revenue beat(12)7
Avg Revenue beat(12)0.24%
Revenue beat(16)7
Avg Revenue beat(16)-0.59%
PT rev (1m)-12.72%
PT rev (3m)-22.57%
EPS NQ rev (1m)-56.54%
EPS NQ rev (3m)-56.54%
EPS NY rev (1m)-44.54%
EPS NY rev (3m)-44.93%
Revenue NQ rev (1m)-5.09%
Revenue NQ rev (3m)-5.09%
Revenue NY rev (1m)-3.63%
Revenue NY rev (3m)-4.58%
Valuation
Industry RankSector Rank
PE 42.65
Fwd PE 10.48
P/S 0.6
P/FCF 51.64
P/OCF 12.8
P/B 0.77
P/tB 1.69
EV/EBITDA 21.24
EPS(TTM)0.37
EY2.34%
EPS(NY)1.51
Fwd EY9.54%
FCF(TTM)0.31
FCFY1.94%
OCF(TTM)1.23
OCFY7.81%
SpS26.15
BVpS20.53
TBVpS9.33
PEG (NY)0.11
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.63%
ROE -2.34%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 12.2%
FCFM 1.17%
ROA(3y)0.02%
ROA(5y)2.26%
ROE(3y)0.6%
ROE(5y)4.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.35%
GM growth 5Y-2.65%
F-Score6
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 12.16
Debt/EBITDA 4.56
Cap/Depr 101.22%
Cap/Sales 3.55%
Interest Coverage N/A
Cash Conversion 160.66%
Profit Quality N/A
Current Ratio 3.09
Quick Ratio 1.32
Altman-Z 2.54
F-Score6
WACC10.96%
ROIC/WACCN/A
Cap/Depr(3y)62.01%
Cap/Depr(5y)61.74%
Cap/Sales(3y)2.1%
Cap/Sales(5y)1.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)716.67%
EPS 3Y-63.79%
EPS 5Y-33.82%
EPS Q2Q%233.33%
EPS Next Y388.41%
EPS Next 2Y206.76%
EPS Next 3Y123.87%
EPS Next 5Y86.61%
Revenue 1Y (TTM)13.41%
Revenue growth 3Y-8.18%
Revenue growth 5Y6.46%
Sales Q2Q%21.39%
Revenue Next Year12.02%
Revenue Next 2Y9.31%
Revenue Next 3Y8.16%
Revenue Next 5Y12.03%
EBIT growth 1Y73.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year258.23%
EBIT Next 3Y70.83%
EBIT Next 5Y57.86%
FCF growth 1Y-56.61%
FCF growth 3YN/A
FCF growth 5Y-22.51%
OCF growth 1Y-26.04%
OCF growth 3Y22.22%
OCF growth 5Y-13.37%